Nanoviricides Inc
(NNVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,019 | -3,316 | -1,571 | -8,107 | -6,327 |
| Depreciation Amortization | 559 | 370 | 183 | 723 | 535 |
| Accounts payable and accrued liabilities | 34 | 140 | 199 | 41 | -35 |
| Other Working Capital | 124 | 408 | 302 | 215 | 124 |
| Other Operating Activity | 130 | -36 | -146 | 1,237 | 1,209 |
| Operating Cash Flow | $-4,172 | $-2,433 | $-1,033 | $-5,891 | $-4,494 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -149 | -90 | -45 | -324 | -249 |
| Investing Cash Flow | $-149 | $-90 | $-45 | $-324 | $-249 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -95 | -95 | -71 | -235 | -202 |
| Financing Cash Flow | $-95 | $-95 | $-71 | $-235 | $-202 |
| Beginning Cash Position | 14,066 | 14,066 | 14,066 | 20,517 | 20,517 |
| End Cash Position | 9,651 | 11,448 | 12,918 | 14,066 | 15,572 |
| Net Cash Flow | $-4,415 | $-2,618 | $-1,148 | $-6,450 | $-4,945 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,172 | -2,433 | -1,033 | -5,891 | -4,494 |
| Capital Expenditure | -149 | -90 | -45 | -324 | -249 |
| Free Cash Flow | -4,321 | -2,523 | -1,077 | -6,216 | -4,743 |